Breast Care

Papers
(The TQCC of Breast Care is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Kombinationstherapie bei HER2+ mBC56
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?30
PharmaNews24
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation24
Effects and Risks of Hormonal Therapy before and after BC Therapy19
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives18
Front & Back Matter18
Acknowledgement to Reviewers16
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria15
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo – Neotarget Trial12
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study12
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience11
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases11
Front & Back Matter9
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study9
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis9
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database9
Quality of Life after Alloplastic versus Autologous Breast Reconstruction: The Influence of Patient Characteristics on Outcomes8
Sacituzumab govitecan: Trop-2 als Target8
Interview ABC7: Bridging the Gap8
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)8
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients8
Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast7
Quality of Life in Patients Pre- and Post-Breast Reduction Surgery in a South African Population: a single-centred patient-based study7
PharmaNews7
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection6
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue6
Primary Prevention and Early Detection of Hereditary Breast Cancer6
Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations6
Evolution of HER2 Targeting in Metastatic Breast Cancer6
Front & Back Matter5
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis5
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti5
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response5
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience4
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes4
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard4
Clinicopathological Factors Affecting Positive Margins after Breast-Conserving Surgery: A Comparative Study of Low- and High- Volume Hospitals.4
Expert Discussion: SABCS 20214
Analysis of lifestyle and genetic risk factors in urban women in China who had malignant or suspected malignant breast nodules identified via breast cancer screening4
Society Bulletins3
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis3
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution3
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy3
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer3
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”3
Acknowledgement to Reviewers3
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study3
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati3
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery3
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience3
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts3
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data2
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20232
Biomarkers: Which Ones Do We Really Need Today?2
Evaluation of Interreader Agreement between Optimized Short and Full Breast MRI Protocols for Screening Breast Cancer in Moderate- and High-Risk Women2
Revisiting the Need for Breast Imaging in Young Women with Clinically Significant Breast Pain and a Normal Physical Breast Examination2
PharmaNews2
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?2
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving2
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus2
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital2
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20252
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty2
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries2
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey2
PharmaNews2
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation2
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium2
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABC2
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies2
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20242
Front & Back Matter2
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib2
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients2
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level2
0.063818216323853